Cargando…
D-penicillamine in Wilson's disease; recognizing the transition from benefit to harm
Autores principales: | Goh, Yihui, Tan, Benjamin Yong-Qiang, Chong, Nicole Ya-Yuan, Ma, Margaret, Lahiri, Manjari, Makmur, Andrew, Chan, Yee Cheun, Wong, Soon Boon Justin, Vijayan, Joy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994719/ https://www.ncbi.nlm.nih.gov/pubmed/33786384 http://dx.doi.org/10.1016/j.ensci.2021.100328 |
Ejemplares similares
-
Evaluation of vitamin B(6) supplementation in Wilson’s disease patients treated with D-penicillamine
por: Mbala, Justin, et al.
Publicado: (2023) -
Pompholyx-Like Eruptions Induced by Penicillamine in a Patient with Wilson's Disease
por: Devassy, Diana Elizabeth, et al.
Publicado: (2019) -
A rare case of DIC in a patient with Wilson’s disease: D-penicillamine
por: Emre Parlar, Yavuz, et al.
Publicado: (2022) -
D-penicillamine Induced Myasthenia Gravis in Wilson’s Disease: A Case Report
por: Thapa, Lekhjung, et al.
Publicado: (2022) -
Elastosis Perforans Serpiginosa: a D-penicillamine induced dermatoses in a patient with Wilson’s disease
por: Samal, Swagatika, et al.
Publicado: (2020)